Aug 09, 2018
Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results
Jul 03, 2018
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
May 10, 2018
Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results
May 01, 2018
Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018
Apr 25, 2018
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Mar 21, 2018
Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors
Mar 08, 2018
Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results
Jan 31, 2018
Juniper Pharmaceuticals to Explore Strategic Alternatives
Jan 08, 2018
Juniper Pharmaceuticals Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany
Jan 02, 2018
Juniper Pharmaceuticals Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress
Dec 29, 2017
Juniper Pharma Services' co-founder awarded CBE in the Queen's New Year's Honours List
Sep 18, 2017
Juniper Pharmaceuticals Announces Strategic Reprioritization
Sep 11, 2017
Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors
Aug 03, 2017
Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results
Jul 27, 2017
Juniper Pharmaceuticals to Report Second Quarter 2017 Results on August 3, 2017
Jul 05, 2017
Juniper Pharmaceuticals Announces Results of 2017 Annual Meeting